Trial of Iseganan in Prevention of Ventilator-Associated Pneumonia

Summary

This is a multinational, double-blind, placebo-controlled trial designed to assess whether iseganan, applied topically to the oral cavity, can prevent ventilator-associated pneumonia among patients who are intubated and mechanically ventilated and survive for up to 14 days.

Timeline

Start

2003-09

Primary completion

—

Completion

2004-06

Drugs

Indications